We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$745B
AUM Growth
+$33.9B
Cap. Flow
-$10.6B
Cap. Flow %
-1.43%
Top 10 Hldgs %
31.69%
Holding
14,193
New
1,741
Increased
5,205
Reduced
5,319
Closed
1,559

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.17B
2
AMZN icon
Amazon
AMZN
+$1.98B
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.79B
4
NVDA icon
NVIDIA
NVDA
+$1.18B
5
WFC icon
Wells Fargo
WFC
+$827M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.63%
2 Technology 1.89%
3 Consumer Discretionary 1.29%
4 Communication Services 0.93%
5 Healthcare 0.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STEX
11626
PUT
Streamex Corp
STEX
$96.3M
$166K ﹤0.01%
5,560
-290
-5% -$9.43K
RXD icon
11627
ProShares UltraShort Health Care
RXD
$2.91M
$166K ﹤0.01%
5,827
-391
-6% -$10.5K
SCOR icon
11628
Comscore
SCOR
$79.4M
$166K ﹤0.01%
2,127
+755
+55% +$59.8K
KDNY
11629
CALL
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$166K ﹤0.01%
+13,000
New +$171K
SGTX
11630
PUT
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$166K ﹤0.01%
+2,262
New +$174K
KSICU
11631
DELISTED
Kadem Sustainable Impact Corporation Unit
KSICU
$166K ﹤0.01%
16,806
IMLP
11632
DELISTED
iPath S&P MLP ETN
IMLP
$166K ﹤0.01%
+13,185
New +$165K
AGTC
11633
PUT
DELISTED
Applied Genetic Technologies Corporation
AGTC
$166K ﹤0.01%
55,000
+12,700
+30% +$45.2K
ETON icon
11634
PUT
Eton Pharmaceutcials
ETON
$1.79B
$165K ﹤0.01%
32,700
-1,500
-4% -$7.8K
IGC icon
11635
CALL
IGC Pharma
IGC
$34.5M
$165K ﹤0.01%
111,400
-84,300
-43% -$136K
RFIL icon
11636
PUT
RF Industries
RFIL
$118M
$165K ﹤0.01%
20,500
-200
-1% -$1.67K
ZDGE icon
11637
Zedge
ZDGE
$37.9M
$165K ﹤0.01%
+12,318
New +$195K
ACOR
11638
DELISTED
Acorda Therapeutics
ACOR
$165K ﹤0.01%
1,793
-240
-12% -$19.9K
MTCR
11639
DELISTED
Metacrine, Inc. Common Stock
MTCR
$165K ﹤0.01%
+48,099
New +$150K
DSACU
11640
DELISTED
Duddell Street Acquisition Corp. Unit
DSACU
$165K ﹤0.01%
16,408
+5,100
+45% +$51.3K
MNSO icon
11641
MINISO
MNSO
$3.23B
$164K ﹤0.01%
10,764
-24,550
-70% -$375K
NXC
11642
DELISTED
Nuveen CA Select Tax-Free Income Portfolio
NXC
$164K ﹤0.01%
+10,427
New +$171K
OPAD icon
11643
Offerpad Solutions
OPAD
$21.7M
$164K ﹤0.01%
125
-940
-88% -$1.44M
PRPH
11644
DELISTED
ProPhase Labs
PRPH
$164K ﹤0.01%
3,149
-3,779
-55% -$225K
RGLS
11645
CALL
DELISTED
Regulus Therapeutics
RGLS
$164K ﹤0.01%
23,790
-3,440
-13% -$25.2K
SEI
11646
Solaris Energy Infrastructure
SEI
$3.48B
$164K ﹤0.01%
19,719
+7,153
+57% +$58K
GORO icon
11647
CALL
Goldgroup Mining
GORO
$511M
$163K ﹤0.01%
103,600
-11,900
-10% -$22.6K
MOD icon
11648
PUT
Modine Manufacturing
MOD
$9.9B
$163K ﹤0.01%
14,400
-121,900
-89% -$1.7M
OPTT icon
11649
PUT
Ocean Power Technologies
OPTT
$48.3M
$163K ﹤0.01%
70,400
-15,800
-18% -$33.1K
RGLS
11650
PUT
DELISTED
Regulus Therapeutics
RGLS
$163K ﹤0.01%
23,670
-2,450
-9% -$17.9K

Similar funds

Jeff Yass's Q3 2021 Portfolio in Review

As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q3 2021 filing shows 1,741 new, 5,205 increased, 5,319 reduced and 1,559 closed positions. Its largest new stake was InMode: 613,660 shares worth $48.9M. The largest sale was Walt Disney, an estimated $2.17B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
  • Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
  • Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
  • Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
  • Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
  • Jeff Yass opened 1,741 new positions and closed 1,559 in Q3 2021.
  • Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.